$34.14
+1.66 (+5.11%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+22.02%
1Y
+99.07%
YTD
+25.79%
Open$33.58
Previous Close$32.48
Day High$34.35
Day Low$32.66
52W High$36.44
52W Low$15.60
Volume—
Avg Volume2.01M
Market Cap3.51B
P/E Ratio—
EPS$-0.64
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$28.48
Above
SMA 200
$22.69
Above
RSI (14)
44
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
25 analysts
Price Target
+81.8% upside
Current
$34.14
$34.14
Target
$62.07
$62.07
$37.88
$62.07 avg
$80.69
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 145.36M | 110.22M | 476.44M |
| Net Income | -83,208,701 | -56,784,827 | -46,993,180 |
| Profit Margin | -57.2% | -54.4% | -9.9% |
| EBITDA | -375,920,619 | -270,795,107 | -41,088,618 |
| Free Cash Flow | — | — | -33,034,013 |
| Rev Growth | +31.9% | +31.9% | -6.6% |
| Debt/Equity | — | — | 0.22 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |